Effects of exergaming on cognition in individuals with schizophrenia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical intervention focuses on the impact of exergaming on cognitive function and clinical symptoms in outpatient individuals diagnosed with schizophrenia. Participants will engage in two 45-minute exergaming sessions per week for 12 weeks, guided by a personal trainer. The study aims to determine if this innovative approach can enhance cognitive abilities, reduce symptoms, and improve overall quality of life. Results will be compared to previous research conducted at the same site to assess the effectiveness of this intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Having consent capability
* Understanding and speaking Scandinavian language
* Fulfilling the International Classification of Diseases Tenth Revision (ICD 10) criteria for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder and schizophreniform disorder)

Exclusion Criteria:

* Diagnosis of intellectual disability
* Diagnosis of neurological disorder
* History of severe head trauma
* Pregnancy
* Chest pain during exercise
* Unstable angina pectoris
* Malignant hypertension
* Uncontrollable arrhythmia
* Recent myocardial infarction
* Acute infection with lymphadenopathy
* Other specified medical condition incompatible with participation

Where it's running

• DPS Vestfold, Vestfold Sykehus HF
  Tønsberg, Vestfold, Norway Recruiting

Study contacts

• Principal investigator: Tom Langerud Holmen, PhD — Sykehuset i Vestfold HF
• Study coordinator: Tom Langerud Holmen, PhD
• Email: lantom@siv.no
• Phone: 97119323

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• Using Lumateperone to improve motivation in patients with schizophrenia and psychosis

  This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.

  Recruiting Phase 3 Louisiana State University Health Sciences Center Shreveport · Shreveport, Louisiana · NCT06482554

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

• Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders

  This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07395206

• Precision brain stimulation to reduce cannabis craving in people with schizophrenia

  This trial tests whether targeted brain stimulation can reduce cannabis craving and improve thinking in people with schizophrenia who currently use cannabis.

  Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT07196462

• Improving rehabilitation for veterans with serious mental illness

  This study is testing a new computer program to help veterans with serious mental illnesses improve their thinking and daily life skills.

  Recruiting VA Office of Research and Development · San Diego, California · NCT06586164

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.